129 related articles for article (PubMed ID: 25801813)
1. Immunotherapy: Soluble ligands--a new approach to cancer therapy.
Errico A
Nat Rev Clin Oncol; 2015 Jun; 12(6):311. PubMed ID: 25801813
[No Abstract] [Full Text] [Related]
2. Immunology. MULT1plying cancer immunity.
Steinle A; Cerwenka A
Science; 2015 Apr; 348(6230):45-6. PubMed ID: 25838370
[No Abstract] [Full Text] [Related]
3. Distinct mechanisms of tumor resistance to NK killing: of mice and men.
Pardoll DM
Immunity; 2015 Apr; 42(4):605-6. PubMed ID: 25902479
[TBL] [Abstract][Full Text] [Related]
4. Shed NKG2D ligand boosts NK cell immunity.
Narni-Mancinelli E; Vivier E
Cell Res; 2015 Jun; 25(6):651-2. PubMed ID: 25849247
[TBL] [Abstract][Full Text] [Related]
5. Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.
Deng W; Gowen BG; Zhang L; Wang L; Lau S; Iannello A; Xu J; Rovis TL; Xiong N; Raulet DH
Science; 2015 Apr; 348(6230):136-9. PubMed ID: 25745066
[TBL] [Abstract][Full Text] [Related]
6. New twist on the regulation of NKG2D ligand expression.
Cerwenka A
J Exp Med; 2009 Feb; 206(2):265-8. PubMed ID: 19204110
[TBL] [Abstract][Full Text] [Related]
7. NKG2D-MICA Interaction: A Paradigm Shift in Innate Recognition.
Bléry M; Vivier E
J Immunol; 2018 Apr; 200(7):2229-2230. PubMed ID: 29555675
[No Abstract] [Full Text] [Related]
8. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
[TBL] [Abstract][Full Text] [Related]
9. Increasing polymorphism of the RAET1E/ULBP4 gene in humans.
Pearson H; Madrigal JA; Saudemont A; Cox ST
HLA; 2016 Jan; 87(1):63-5. PubMed ID: 26814419
[TBL] [Abstract][Full Text] [Related]
10. Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma.
Belting L; Hömberg N; Przewoznik M; Brenner C; Riedel T; Flatley A; Polić B; Busch DH; Röcken M; Mocikat R
Eur J Immunol; 2015 Sep; 45(9):2593-601. PubMed ID: 26151313
[TBL] [Abstract][Full Text] [Related]
11. Three novel allelic variants of the RAET1E/ULBP4 gene in humans.
Cox ST; Madrigal JA; Saudemont A
Tissue Antigens; 2012 Oct; 80(4):390-2. PubMed ID: 22845659
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of CD24(+) ovarian cancer cells to anti-cancer drugs and natural killer cells.
Koh J; Lee SB; Park H; Lee HJ; Cho NH; Kim J
Biochem Biophys Res Commun; 2012 Oct; 427(2):373-8. PubMed ID: 22995296
[TBL] [Abstract][Full Text] [Related]
14. MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation.
Tietje A; Li J; Yu X; Wei Y
Gene Ther; 2014 May; 21(5):468-75. PubMed ID: 24572784
[TBL] [Abstract][Full Text] [Related]
15. Pillars Article: Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA.
Bauer S; Groh V; Wu J; Steinle A; Phillips JH; Lanier LL; Spies T
J Immunol; 2018 Apr; 200(7):2231-2233. PubMed ID: 29555676
[No Abstract] [Full Text] [Related]
16. Four novel ULBP splice variants are ligands for human NKG2D.
Cao W; Xi X; Wang Z; Dong L; Hao Z; Cui L; Ma C; He W
Int Immunol; 2008 Aug; 20(8):981-91. PubMed ID: 18544572
[TBL] [Abstract][Full Text] [Related]
17. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma.
Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G
Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020
[TBL] [Abstract][Full Text] [Related]
18. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.
Chitadze G; Bhat J; Lettau M; Janssen O; Kabelitz D
Scand J Immunol; 2013 Aug; 78(2):120-9. PubMed ID: 23679194
[TBL] [Abstract][Full Text] [Related]
19. The role of microRNAs in the control of innate immune response in cancer.
Jasinski-Bergner S; Mandelboim O; Seliger B
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25217579
[TBL] [Abstract][Full Text] [Related]
20. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
Mei JZ; Guo KY; Wei HM; Song CY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]